Daito Pharmaceutical Co.,Ltd. [4577.T]

TOKYO, Apr 01 (Pulse News Wire) – Daito Pharmaceutical Co., Ltd. (4577.T) announced progress on its share repurchase program.

The company acquired 208,800 shares for a total of ¥305,442,800 through open market purchases. The board authorized the repurchase of up to 1,000,000 shares with a maximum expenditure of ¥1,500,000,000.

The program is 88.3% complete with 883,200 shares acquired to date.

Share buyback

Shares

208,800 shares

Total cost

¥305M

Avg ¥1,463/share

Period

2026-03-01

Progress vs authorization

208,800 shares of 1.0M shares (20.9%)

Source: TDNet filing

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.